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optimize these pathways and thus to guar-
antee their maximum chance of survival, 
cells produce enzymes at precise and con-
stant rates.[4] However, because of cellular 
complexity, determination of optimal 
enzyme levels is still unclear, in particular 
because specific enzymatic functions are 
strongly interconnected with their cas-
cade effects.[5] A smart manner to study 
the behavior of enzymes, when involved 
in complex reactions, consists of taking 
advantage of synthetic micrometer-sized 
compartments shaped into spherical 
architectural bodies.[6–8] Though these 
idealized models favor even partitioning 
of membrane proteins and simplify dif-
fusion gradients, similarly to cells, they 
provide the desired membrane selectivity 
and permeability.[9,10]
Single specific functions have been pre-
sented by combining enzymes (the catalytic 
compounds) with synthetic supramolecular 
assemblies, either intrinsically semiperme-
able, such as lipid-coated porous silica par-
ticles,[11] protein cages,[12] layer-by-layer cap-
sules,[13–15] and polydopamine capsules,[16,17] 
or rendered permeable by the insertion of 
biopores/membrane proteins (acting as 
”gates” for the passage of molecules), as in lipid-based[7,18,19] or 
polymer-based[8,20–22] giant unilamellar vesicles (GUVs).
At present, GUVs formed with amphiphilic block copoly-
mers are particularly appealing because they provide enhanced 
structural membrane properties compared to lipids, since they 
possess compartments with higher chemical versatility, con-
trolled permeability, robustness, and stability.[23] Nevertheless, 
common approaches to form polymer GUVs by self-assembly, 
as electroformation[24] and film-rehydration,[25] rely on the sta-
tistical process of encapsulation of biomolecules with a prob-
ability of finding the designed amount of one type of enzyme 
inside the compartments ranging from 12–57%. In the con-
text of elementary biochemical pathways where at least two 
enzymes are present, this scenario is even more unsatisfactory, 
with co-encapsulation of two enzymes inside one compart-
ment as low as 10–22%.[26,27] These shortcomings are worsened 
by the fact that these probabilities have a large uncertainty 
induced by specific properties of enzymes (e.g., solubility and 
stability). To date, scientists have struggled to work with state-
of-the-art average values for number/mass of enzymes that 
are vastly non-representative (limited by a small sample size) 
Cells rely upon producing enzymes at precise rates and stoichiometry 
for maximizing functionalities. The reasons for this optimal control are 
unknown, primarily because of the interconnectivity of the enzymatic 
cascade effects within multi-step pathways. Here, an elegant strategy for 
studying such behavior, by controlling segregation/combination of enzymes/
metabolites in synthetic cell-sized compartments, while preserving vital cel-
lular elements is presented. Therefore, compartments shaped into polymer 
GUVs are developed, producing via high-precision double-emulsion micro-
fluidics that enable: i) tight control over the absolute and relative enzymatic 
contents inside the GUVs, reaching nearly 100% encapsulation and co-
encapsulation efficiencies, and ii) functional reconstitution of biopores and 
membrane proteins in the GUVs polymeric membrane, thus supporting 
in situ reactions. GUVs equipped with biopores/membrane proteins and 
loaded with one or more enzymes are arranged in a variety of combinations 
that allow the study of a three-step cascade in multiple topologies. Due to 
the spatiotemporal control provided, optimum conditions for decreasing 
the accumulation of inhibitors are unveiled, and benefited from reactive 
intermediates to maximize the overall cascade efficiency in compartments. 
The non-system-specific feature of the novel strategy makes this system an 
ideal candidate for the development of new synthetic routes as well as for 
screening natural and more complex pathways.
In living cells, there exists an incredible variety of sequential 
chains of reactions. These so-called reaction pathways are cat-
alyzed by mutually compatible and selective enzymes, which 
perform central functions, such as breaking down toxins,[1] 
converting nutrients into energy,[2] or duplicating DNA.[3] To 
© 2020 The Authors. Published by Wiley-VCH GmbH. This is an open 
access article under the terms of the Creative Commons Attribution 
License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited.
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and extremely low, due to severe dilution as a result of the self-
assembly processes.[28,29]
Double emulsion microfluidics has a significant role to play 
in the fine control of these parameters (encapsulated content 
and membrane compositions), coupled with the capability for 
high-throughput and on-demand generation.[30] However, while 
double emulsions have been extensively used to form GUVs for 
programmed release of encapsulated hydrophilic[31–33] and/or 
hydrophobic[31,34] cargos, their capabilities are still undeveloped 
for the study of enzymatic pathways, where they are expected 
to have substantial advantages. In this respect, double emul-
sions can serve as templates for producing ideal cell-sized 
compartments with precise control of properties, such as: 
i) size (as per design) and extremely narrow size distribution; 
ii) internal biomolecular content and distribution; iii) mem-
brane organization, that is, synthetic membrane composition 
and insertion of peptides/membrane proteins; and ultimately, 
iv) features for enzymatic reactions and pathway signaling.
Here, we introduce a novel strategy for studying multi-step 
enzymatic reactions inside tailored synthetic compartments, 
systematically arranged in a variety of combinatorial configura-
tions. These compartments in the form of polymer GUVs have 
been produced via the high precision double emulsion tech-
nique, which allows the vital control of the amount/number/
ratio of encapsulated enzymes. Moreover the technique has 
been optimized to render the membrane of the GUVs perme-
able for diffusion of enzymatic substrates/products in and out 
of the compartments to support in situ enzymatic reactions. 
To obtain GUVs with essential properties for insertion of pep-
tides/membrane proteins that make their membranes per-
meable, we selected amphiphilic block copolymers, based on 
poly(dimethylsiloxane) (PDMS) and poly(2-methyl-2-oxazoline) 
(PMOXA) as the corresponding hydrophobic and hydrophilic 
domains, which have already been used to produce GUVs 
with the required fluidity and flexibility.[35] Together with the 
enzymes encapsulated inside the GUVs, equipping GUVs with 
biopores/membrane proteins allows investigation of multi-step 
cascade reactions via the spatial segregation/combination of 
various enzyme types in different compartments. A three-step 
cascade reaction, based on well-known enzymes, was selected 
as a model to provide evidence on how the overall reaction 
can be affected by compartmentalization and single enzyme 
behavior. A combinatorial strategy based on a plethora of pos-
sible segregation configurations, for example, with enzymes 
separated from one another or in several combinations of 
encapsulation and co-encapsulation scenarios, was facilitated 
by the straightforward manner in which double emulsion 
microfluidics controls the production of the enzyme-loaded 
GUVs. Thanks to the constant enzyme molar ratios provided by 
our method, effects, such as the proximity of enzyme and 
metabolites, and molecular diffusion through membranes have 
been decoupled, thus allowing limiting factors to be under-
stood and cascades optimized. This fine spatial control provides 
optimum conditions for reducing competing side reactions, 
decreasing the accumulation of inhibitory or reactive interme-
diates, and ultimately increasing reaction rates by maximizing 
the cascade productivity.
Furthermore, this strategy allows the steps for studying 
and optimizing complex cascade reactions to be established 
in a controlled space and time manner, without involving 
the difficult and time consuming labor of varying enzymatic 
concentrations. Thus, our combinatorial study represents a 
system-independent tool for coordinating multi-step path-
ways, with complexity closer to that of cells for exploring new 
domains of application.
In the literature, two separate approaches have been used for 
the creation of double emulsion templated GUVs in microflu-
idic devices, using glass capillaries or molded in PDMS. Each 
one has its own advantages and limitations. Glass capillaries 
have been widely used for production of different types of cap-
sules,[32,36,37] including GUVs with ultra thin shells,[38,39] but 
the device production and operation are quite challenging: If 
capillaries are misaligned or not well sanded, instabilities can 
occur and double emulsions might not be produced because 
of uncontrolled encounter of the fluids.[40] Reproducible fab-
rication of microfluidic devices is more easily achieved if they 
are made from masks and molds, which is predominantly the 
case when soft lithography is employed to fabricate microchips 
made from PDMS.[41] However, despite rapid prototyping and 
easy replication, there are difficulties in modifying the chemical 
properties of PDMS surfaces to tune their wettability toward 
different fluids.[38] Forming double emulsions in these condi-
tions requires the oil phase enveloping the inner droplets to be 
thicker to avoid their collapse, and this may prevent assembly of 
the GUVs.[42] Thus, to obtain GUVs with a homogeneous poly-
meric membrane that favors biopore/membrane protein inser-
tion, a higher level of precision and reproducibility is required 
for generating double emulsions with thin organic shells, 
which neither glass capillaries nor PDMS microdevices alone 
can in the long run provide. For this reason, we now combine 
the best characteristics of both aforementioned approaches 
to produce novel microfluidic devices that are based on high-
resolution solid-state manufacturing and aim at exploiting the 
high chemical and mechanical compatibility of silicon-glass 
devices. For that purpose, channels were etched into a silicon 
(Si) substrate using deep-reactive ion etching (DRIE) (that pro-
vides rectangular cross-sections with a desired depth, described 
in Supporting Information), and were closed with glass covers 
by anodically bonding them to the Si substrate. Both the 
native oxide of the Si bottom channel walls as well as the glass 
channel top wall offer universal solvent compatibility (avoiding 
channel swelling) and multiple ways to control surface chem-
istry. Furthermore, the architecture provides a high mechanical 
robustness, in particular compared to PDMS-based devices, 
which prevents oscillatory ”breathing” of the channels upon 
operation, preserving the geometry of the junction, important 
for double-emulsion generation.[43]
While the initial design of our microchips was based on an 
existing six-way junction,[44] several improvements in the geom-
etry were necessary for optimal double emulsion formation 
and flow to collection (Figure S1, Supporting Information). To 
create double emulsions, the silicon-glass channels were func-
tionalized to locally control the wettability within regions of the 
microchip, where channel properties were made hydrophilic or 
hydrophobic (Figure S2, Supporting Information).
Polymer stabilized water-oil-water double emulsions were 
generated by feeding immiscible fluids with defined flow 
rates into the six-way junction (Figure 1). In such a geometry, 
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resulting from the combination of co-flowing and flow-
focusing junctions, the inner aqueous (IA) phase stream 
enclosed by the polymer organic (PO) phase (due to its affinity 
toward the channel wall) advances downstream from the 
hydrophobic side to the hydrophilic main channel, up to the 
point, where surface forces no longer hold the shear provoked 
by the outer aqueous (OA) phase (which preferentially wets 
these channels), and the break-up occurs. In coaxial glass cap-
illaries[37,45] and in planar devices,[46] where either co-flowing or 
two serial flow-focusing junctions were used, dripping insta-
bilities only allowed for pinching the inner drop before the 
outer jet, and a mixture of single and double emulsion drop-
lets were mainly produced.[40] However, our six-way junction 
not only provided monodispersed double emulsions with the 
desired thin shells at 100% production efficiency (after opti-
mization of flow rates), but also at high OA phase flow rates 
(50–80  µL min−1) providing a simultaneous high-throughput 
break-up of both fluids (IA and PO) in a single step (Movie S1, 
Supporting Information).
The excellent ability to control size and composition that 
our microfluidic devices offer should allow GUVs to be 
equipped not only with small biomolecules, such as car-
boxyfluorescein, but also larger ones, such as proteins, 
both in the inner cavity and inside the polymer membranes 
(Figure 1). Their modularity yielded a variety of GUV arrange-
ments that allow the study of enzymatic cascade reactions. 
For constructing robust, and at the same time flexible, cell-
sized compartments for assisting insertion of biochannels,[23] 
the amphiphilic diblock copolymer poly(dimethylsiloxane)-
block-poly(2-methyl-2-oxazoline) (PDMS26-b-PMOXA9) was 
synthesized and purified according to previously reported pro-
tocols.[47,48] The copolymer was added to the PO phase, first 
to stabilize the double emulsion, and subsequently, to form 
the supramolecular membrane of the GUV. In principle, our 
microfluidic platform could also produce lipid-GUVs, since 
this has been already done, both in glass capillary devices,[38] 
as well as in PDMS chips.[44] In that case, a lipid-carrying 
organic phase would be fed at the PO phase channel, instead 
Figure 1. Microfluidic process of simultaneous double emulsion generation and functionalization. Schematic representation of the high-throughput 
double emulsion generation process for creating compartments (giant unilamellar vesicles, GUVs, [Movie S1, Supporting Information]) containing 
precise amounts of biomolecules in a plethora of possible combinations in their inner aqueous cavity and inside their polymer membrane. a–i) Rep-
resentation of the various inner aqueous (IA) biomolecular content. I,II) Representation of the different outer aqueous (OA) phases. Schematic: I,a) 
Impermeable GUVs loaded with aqueous solution of carboxyfluorescein, and I,b) GUVs equipped with the biopore gramicidin. Schematic of GUVs 
equipped with the outer membrane protein, OmpF, and loaded with aqueous solutions of enzymes, β-galactosidase, glucose oxidase, and horseradish 
peroxidase, encapsulated/co-encapsulated as: II,c–e) singlets (one enzyme); II,f–h) duplets (two enzymes); and II,i) triplets (three enzymes). Scale 
bar: 100 µm.
Adv. Mater. 2020, 32, 2004804
© 2020 The Authors. Published by Wiley-VCH GmbH2004804 (4 of 13)
www.advmat.dewww.advancedsciencenews.com
of the selected copolymer. However, this is out of the scope of 
the current work.
In addition, we aimed to mimic elements of the complex 
interiors of cells, by loading precise amounts of enzymes into 
GUVs. Hence, one, two, or three types of enzymes were added 
to the IA phase in predefined amounts, either one at a time, in 
pairs, or all at once. For triggering the cascade reaction, and in 
general for providing communication between the constructed 
compartments, either a pore-forming peptide was added to the 
IA phase, or a membrane protein was added to the OA phase 
(Figure  1). Both strategies for double emulsion formation 
enabled a controlled reconstitution of the biochannels (each 
offering a specific molecular flow), in a reproducible manner 
during the process of reorganization of the polymeric chains 
into the GUV membrane.
Polymer GUVs formed using double emulsions as tem-
plates do not rely on the self-assembly of amphiphiles in 
bulk.[40] Instead, these amphiphiles self-assemble at the two 
liquid liquid interfaces of the double emulsions and form two 
monolayers, which are brought together during solvent evapo-
ration, and finally shape into a membrane bilayer. As a result 
of the thin shell of the produced double emulsions, such a 
transition occurred within minutes and resulted in GUVs 
with a homogeneous membrane composition that is ideal for 
inserting biochannels.
Droplets produced by dripping, in which their pinch off 
occurs near the tip before entering the main channel, are 
typically highly monodispersed,[45] but strongly dependent on 
parameters, such as the capillary number, Ca (Ca = μv/γ, where 
the numerator accounts for the viscous shear stress and the 
denominator for the interfacial forces[49]), the viscosity ratio, and 
the junction geometry. Understanding how these parameters 
influence the double emulsion formation, and ultimately the 
GUV size and size distribution, is of fundamental importance 
to achieving the thin shell thickness and desired regularity of 
GUVs. Since the flow dynamics underlying the break-up mech-
anism of double emulsions is rather difficult to simulate and 
predict, scaling laws for GUV sizes are not established.[50,51] 
Hence, we perform empirical optimization for conditions 
where double emulsions were in flow to examine the influ-
ence of, first, the outer aqueous (OA) flow rate on the droplet 
break-up, and second, the inner aqueous (IA) flow rate on the 
double emulsion organic shell thickness. The outer and the 
inner diameter of the double emulsions (Figure 2a) were meas-
ured using an automated image processing software written in 
Matlab (Supporting Information) to enable statistically relevant 
numbers of GUVs to be analyzed. For a specific example, 2361 
droplets were measured and found to have size distributions 
with mean diameter of the inner, Din, and the outer shell, Dout, 
of 35.54 and 47.80  µm, respectively, and very narrow polydis-
persities (i.e., relative standard deviations, DD /σ ) of around 
1.70% (Figure 2b). This same procedure was applied to obtain 
mean diameters and polydispersities of all double emulsion 
populations generated, so that their size homogeneity could 
be guaranteed.
First, the flow rate ratio of the inner aqueous phase to the 
polymer organic phase was set to an intermediate and fixed 
value, that is, QIA/QPO  = 2, whereas the outer aqueous phase 
flow rate, QOA, was varied between 10 and 80  µL min−1, 
covering about an order of magnitude of Ca numbers. Both 
inner and outer diameters decreased when QOA was increased, 
but reached a plateau after a certain value (Figure  2c). When 
this threshold was exceeded (for QOA > 40  µL min−1), the influ-
ence of the junction geometry on the double emulsion size 
prevailed over the viscous shear stresses. Consequently, if neces-
sary, double emulsion mean sizes can be reduced by decreasing 
the junction dimensions accordingly; smaller channels can be 
easily etched in the silicon substrate (with micrometer preci-
sion[52]). It is interesting that the same general behavior was not 
only already reported for similar geometries producing double 
emulsions,[32,53] but also for simple T-junctions operating at 
much lower capillary numbers.[54,55] This suggests that despite 
their apparent complexity, at the dripping regime double emul-
sions follow the same rules of formation as single droplets, as 
long as the inner droplet is stable inside the envelope of the 
organic phase. Second, the OA phase flow rate was set to a 
constant value above the threshold, that is, QOA = 50  µL min−1, 
and the flow rate ratio QIA/QPO was varied. For values below 
1, single oil droplets break up in between double emulsions, 
whereas for values larger than 2.5, surface forces on the oil 
side do not hold and the droplet blows up before the junc-
tion; both are undesirable situations (hence not shown). Sizes 
of the double emulsions were nearly independent for QIA/QPO 
between 1–2.5 (Figure  2d). On one hand, this implies we can 
profit from the versatility of the system and operate anywhere 
in this window, but on the other hand, we have no means 
of reducing further the organic phase shell thickness. Note 
that this behavior is only valid if QOA is sufficiently high and 
above the threshold mentioned above (Figure 2c,d). Overall, by 
using the six-way junction geometry together with specific flow 
rates and flow rate ratios among the fluid phases, we have suc-
cessfully generated double emulsions that were surrounded by 
a thin organic shell.
Finally, to obtain GUVs from double emulsion templates, 
the middle organic phase has to partition out of the droplet, 
the so called ”dewetting”.[38,56] This is a complex process, 
which depends, among other things, on solute–solvent 
attractions (solubility), solvent vapor pressure, and on the 
attractive forces between the molecules at the fluid interfaces. 
A correct balance of such energies would result in a complete 
dewetting.[57] However, despite efforts and claims of ”solvent-
free” GUV formation,[44,57,58] from the best of our knowledge, 
as of today, there exists no work that could eliminate the pos-
sibility of remaining solvent traces in the membrane bilayer. 
Similarly, in our system, the dewetting process occurred very 
fast (it could not be measured) up to a certain extent; that is, 
it reached an equilibrium state, which consisted of having a 
small, but visible oil/polymer pocket on the GUV surface that 
stayed there even after days (inset in Figure 2e). For estimating 
size and size distribution, the resulting GUVs were imaged 
by confocal laser-scanning microscopy (CLSM) (Figure  2e). 
Diameters were obtained by treating the acquired microscopy 
images with the same image processing software as that used 
to measure the diameter of the double emulsions. As a result 
of the precise control of double emulsion sizes (Din and Dout), 
GUVs have similar very narrow size distributions (Figure 2f), 
with diameters of 38.14 ± 1.4  µm (± 3.7%). This is in contrast 
to polymer GUVs formed by direct self-assembly in dilute 
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solutions, which had a larger size distribution, in the range 
between 2 to 40  µm.[28,59]
Additionally, as the amphiphilic diblock copolymer 
PDMS26-b-PMOXA9 was employed for assembly of the com-
partments, we expect the GUVs to be impermeable to small 
molecules.[24,28] Nonetheless, since the method of GUV for-
mation influences the mode of self-assembly, it might also 
induce changes in the membrane permeability. To ensure that 
GUVs are impermeable, a fluorescent dye, carboxyfluorescein 
(CF, 376 Da) was loaded into GUVs as representative of the 
molecular weight of several molecules of biological interest, 
such as disaccharides or nucleotides,[60] and the change in flu-
orescence intensity inside the core of the GUVs was followed 
over a period of 9 h at 1 h intervals (Figure 2g–i). The minimal 
signal change (within the deviation) indicated that in spite of 
the existence of a small oil pocket, GUVs were impermeable. 
Being able to preserve this characteristic is important for trig-
gering permeability in a controlled fashion.
Inspired by the self-regulation of activity and signaling path-
ways enabled by cell membranes, we explored functionalities 
which favor inward and outward flow of selected ions and 
molecules by equipping membranes of GUVs with channels 
that enable in situ reactions.[24,27,28,61] For screening possible 
functionalities, we selected two different well-known and stable 
biomolecules,[62–64] a polypeptide and a transmembrane protein, 
which differ greatly in size, shape, and transport specificity, 
thus having different effects on membrane permeability.[8,24] 
When peptides/membrane proteins are reconstituted into the 
GUVs membrane, its thickness is irrelevant; the pores will 
allow the selected ion/molecule to flow inward and will trigger 
the specific process, if they preserve their functionality. On the 
contrary, channel sizes are always associated to the particular 
Figure 2. Optimization of double emulsion sizes and characterization of sizes and permeability of GUVs. a) Representative image of double emulsions 
flowing in the main channel of the microfluidic chip; the outer diameters (red circles) and the inner diameters (blue circles) of the double emulsions 
were measured using image processing software written in Matlab; scale bar 100 µm; inset: visualization of how well features of outer and inner 
diameter were captured by the software. b) Histograms and their corresponding regressed normal distributions out of 2361 measured droplets; mean 
diameter of the inner droplet, Din  = 35.54  µm and the outer shell diameter, Dout = 47.80 µm. Both size distributions resulted in polydispersities 
(i.e., relative standard deviations, DD/σ ) of around 1.70%. c) Inner and outer diameter variation as a function of the outer phase flow rate, QOA, at a 
fixed flow rate ratio, QIA/QPO = 2. d) Inner and outer diameter variation as a function of the flow rate ratio, QIA/QPO, at a constant outer phase flow 
rate QOA = 50  µL min−1. Error-bars are given by the standard deviation. The dashed lines represent ±5% deviation from the mean diameter (center 
line). e) Exemplary CSLM image of the resulting polymer GUVs; scale bar: 50 µm. The diameters of the GUVs (green circles) were measured using 
the same software as (a); inset: zoom-in of a GUV containing a pocket on its upper surface. f) Histogram and its regressed normal distribution out 
of 80 measured GUVs; mean diameter, D  = 38.14  µm and DD/σ  = 3.7%. g) CLSM image of GUVs loaded with carboxyfluorescein at the beginning 
of the permeability experiment (t = 0); scale bar 20 µm. h) Fluorescence signal intensity measured along the centerline of three representative GUVs. 
i) Fluorescence intensity change over time.
Adv. Mater. 2020, 32, 2004804
© 2020 The Authors. Published by Wiley-VCH GmbH2004804 (6 of 13)
www.advmat.dewww.advancedsciencenews.com
enzymatic reaction; hence, depending on them, molecules of 
lower or higher molecular mass will be allowed to cross the 
membrane. Exactly as in nature, each membrane has a specific 
cutoff and functionality.[4,28]
The insertion of membrane proteins inside synthetic mem-
branes relies on membrane properties such as thickness, sur-
face roughness, and curvature.[65] These dependencies make 
insertion and chemical integrity preservation of the biomol-
ecule a difficult task, particularly in polymeric membranes.[62] 
However, despite the much ticker membrane of polymer-
somes, the high flexibility of PDMS provides membrane flu-
idities allowing successful insertion of membrane proteins that 
must overcome the significant higher hydrophobic mismatch 
between their size and the membrane thickness; this is a key-
factor for membrane proteins incorporation.[7,9]
First, specific permeability of GUV membranes was probed 
by inserting a biopore, the pore-forming peptide gramicidin 
(gA), which allows controlled passage of protons and other 
monovalent cations.[24] Then, we aimed to equip the GUV 
membranes with protein channels that induce permeability of 
enzymatic substrates/products, and selected the bacterial outer 
membrane protein F (OmpF), which enables a size selective 
molecular flow up to 600 Da.[8,62,64]
Both OmpF and gA have already been inserted in synthetic 
membranes based on PDMS and PMOXA copolymers,[9,29,35] 
but whereas OmpF was reported to be functional inside 
membranes affording a significant mismatch (up to 6 times) 
between its pore length and the membrane thickness of the 
polymer GUVs, gA preserved functionality only in membranes 
with a maximum thickness of 12.1 nm, resulting in a mismatch 
of approximately 4.5 times.[24] Thus, the PDMS26-b-PMOXA9 
diblock copolymer used in this study, with an estimated thick-
ness of 12.6 ± 1.3 nm (Supporting Information), was carefully 
selected so as not to exceed significantly the literature threshold 
for the biopore/membrane protein insertion. Since control of 
the amounts of biomolecules that can be loaded into GUVs 
formed via double emulsions is the most important advantage 
of this technique, peptides and membrane proteins were intro-
duced into the system (one at a time) during the generation of 
double emulsions in the microfluidic device (Figure 1). Grami-
cidin added to the IA phase for forming the inner droplet, 
enveloped by the organic phase, was the best strategy to present 
the largest surface, which thus favors diffusion and final recon-
stitution of the biopore in the membrane. To assess the bio-
molecular interactions via CLSM, gA was co-entrapped with a 
hydrophilic dye, Sodium Green (SG), which emits fluorescence 
in the presence of Na+ ions. The increase in fluorescence inside 
GUVs, associated with the inflow of Na+ after addition of an 
external NaCl solution, indicated successful gA insertion in the 
synthetic membrane (Figure 3a) (Movie S2, Supporting Infor-
mation), even though the latter is roughly 4.8 times thicker 
than the gA pore length.[24] Further control experiments can be 
found in Figure S6, Supporting Information.
OmpF was added to the OA phase. At high QOA (still at the 
laminar regime), OmpF aggregates flowed downward, together 
with the polymer stabilized double emulsions in the main 
channel, and controlled close contact was promoted between 
OmpF and the polymer molecules, so as to facilitate its penetra-
tion. This new mechanism follows a strategy known to assist 
efficient membrane protein recruitment, as to profit from the 
Figure 3. GUVs equipped with biopores and membrane proteins. According to the corresponding top schematics, CLSM images show: a) GUVs 
equipped with biopore gramicidin (gA), containing sodium Green (SG), which increased fluorescence after the passage of Na+ ions through the gA 
formed pore. b) On the left-hand-side (l.h.s), GUVs containing the enzyme β-galactosidase (β-gal), in the absence of the pore-forming outer membrane 
protein F (OmpF), did not allow the substrate resorufin galacto pyranosidase (RGP) to penetrate the polymer membrane; the red fluorescence signal 
is flat (inset). On the right-hand-side (r.h.s), GUVs containing β-gal and equipped with OmpF allowed RGP to penetrate the polymer membrane and 
react, yielding the fluorescence product resorufin; the red fluorescence signal is high inside the GUV (area of production) and lower outside, after 
product outflow (inset). c) Size selectivity. On the l.h.s, GUVs equipped with OmpF restricted the passage of the fluorescein isothiocyanate dextran 
(FITC-dextran, 10 kDa). On the r.h.s, GUVs equipped with OmpF allowed the passage of carboxyfluorescein (CF, 376 Da). Scale bar: 20  µm.
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low membrane stability at the early stage of its formation pro-
cess.[65] In addition, during the dewetting, as the two leaflets of 
the bilayer approach, the osmotic imbalance causes the inner 
core to shrink as water leaves, unless OmpF insertion happens 
and the new pore helps to equalize the osmotic pressure. Thus, 
the higher osmolarity of the collection phase (CP) might also 
have played a role in destabilizing the membrane and aided full 
transmembrane protein insertion during reorganization of the 
polymeric chains in the GUVs membrane.[66,67]
Therefore, to assess the functionality of OmpF insertion, 
GUVs with and without inserted OmpF, which contained the 
enzyme β-Galactosidase (β-gal), were exposed to the enzymatic 
substrate, resorufin galacto pyranoside (RGP), and the change 
in fluorescence intensity along the GUV centerlines was 
detected in the acquired CLSM images (exemplary signal varia-
tions are shown in the insets of Figure 3b). These indicate that 
when OmpF was present, RGP diffused inside the GUV lumen, 
resulting in a fast production of resorufin (Figure 3b), while in 
the absence of OmpF, no fluorescence signal associated with 
resorufin was detected. In addition, the OmpF functionality 
was further explored for inward diffusion of molecules smaller 
than the OmpF cutoff. Diffusion of the dye carboxyfluorescein, 
which is smaller than 600 Da, through the GUV membrane 
was detected after 24 h in the acquired microscopy images 
(Figure 3c) by an increase of the fluorescence intensity of about 
150% (Figure S7, Supporting Information). As expected, larger 
molecules, such as fluorescein isothiocyanate dextran (FITC-
dextran, 10 kDa), did not penetrate, as only a minor change in 
signal intensity was observed (which after a t-test was shown to 
be insignificant at a significance level, p < 0.05) (Figure S7, Sup-
porting Information). The results, and particularly our controls, 
support the impermeability findings and also highlight the 
lack of defects (no leakage) of the polymeric GUV membranes, 
which represents an important advantage over lipidic GUVs.
OmpF was also added to the IA phase when forming the 
double emulsions, and following the same reasoning as for gA, 
it was expected that confinement would result in the maximum 
surface contact for OmpF insertion. However, since the OmpF 
solution was fed at low flow rates and in the form of a slurry of 
aggregates, because of the absence detergent (necessary to keep 
OmpF solubilized), it entered the microchip channel intermit-
tently, which hampered its final membrane penetration. Thus, 
incorporation of OmpF in the polymeric membrane was more 
successfully performed when it was added to the OA phase 
(Figure S7, Supporting Information).
Lastly, as both OmpF and gA have no directional flux, all 
biopores incorporated in the membrane of the GUVs are 
functional and serve for molecular flow-through. Thus, with a 
rough estimation (Supporting Information), we obtained a total 
amount of 1 × 106 molecules of OmpF and of 3× 106 molecules 
of gA per GUV, which corresponds to 254 OmpF µm−2 and 
710  gA  µm−2. Overall, when equipped with biopores/mem-
brane proteins, GUVs formed by PDMS26-b-PMOXA9 fulfill the 
complex requirements of permitting molecular flow, and mim-
icking various conditions for cell communication, ranging from 
unselective permeability of molecules with limited weights to 
very precise reactions, in which bio-specificity is needed.
Certain fundamental similarities are shared between dif-
ferent cell types. Specifically, they contain the same proportion 
of enzymes within cells, which coordinate biochemical reac-
tions.[4] Thus, providing conditions in which the relative 
amounts of enzymes are tightly controlled is vital for mim-
icking complex cell environments for optimizing biochemical 
pathways. Forming GUVs via the double emulsion microflu-
idics overcomes the issues caused by stochastic encapsulation 
of the self-assemblies, such as low and distributed concen-
trations of enzymes.[62] To date, double-emulsion templated 
polymer GUVs have primarily been employed in cargo delivery, 
where maintaining the inner concentration constant was prob-
ably not crucial, since it was rarely quantified.[31,56,68] To conduct 
multi-step cascade reactions inside compartments, keeping the 
stoichiometry between enzyme concentrations is of extremely 
importance. Thus, to quantify the concentration of encap-
sulated enzymes (Figure  4a–f), encapsulation and co-encap-
sulation efficiencies of fluorescence-labeled enzymes were 
estimated inside GUVs (with negligible change in size due to 
difference in osmolarity of the phases) by brightness measure-
ments associated with fluorescence correlation spectroscopy 
(FCS) (Experimental Section). Thus, brightness measurements 
were conducted for two model enzymes, β-galactosidase (β-gal) 
conjugated with Cy5 and glucose oxidase (GOx) conjugated 
with OregonGreen in the cases where each enzyme type was 
individually loaded (Figure 4a, β-gal and b, GOx, respectively), 
and in the case where the two types were loaded together in 
the same GUV (Figure  4d). However, horseradish peroxidase 
(HRP) conjugated with Atto 550 associated with the mem-
brane because of its hydrophobic properties, thus preventing its 
measurement (Figure 4c).
The encapsulation efficiency, EE, was calculated as 
EE c ce / 1000= × %, where c0 is the measured concentration 
of a single enzyme in the solution used to prepare the GUVs 
(inner aqueous (IA) composition, Experimental Section), and 
ce is the measured concentration of the same enzyme inside 
the GUV. Similarly, co-encapsulation, cEE, was calculated as, 
cEE = ×c c2 / 100e 0 %; this quantity was multiplied by two, 
since the two enzyme types with their respective c0 were added 
together in a 1:1 mass ratio when forming the GUVs. Encap-
sulation and co-encapsulation efficiencies reached nearly 100% 
within the experimental statistical resolution, indicating that 
the double emulsion technique provides great control of the 
biological content inside the GUV and a very high encapsu-
lation efficiency is achieved (Table  1). This feature is key and 
makes our platform great for screening/studying/optimizing 
multi-steps cascade reactions.
Overall, we show that microfluidics can not only allow pre-
cise amounts of enzymes and stoichiometric ratios of different 
types of enzymes to be placed inside compartments, but also 
allow the production of large populations of GUVs with uni-
formly distributed concentrations. Hence, for the first time, 
high concentrations of encapsulated enzymes could be achieved 
almost deterministically and in a controlled manner inside 
GUVs, which compensate the limiting diffusion distances,[3,69] 
and support the optimization of biochemical pathways.
To study multi-enzymatic pathways, we take advantage of the 
capabilities of our microfluidic method to construct synthetic 
compartments with guaranteed absolute and relative enzymatic 
quantities, which are spatially segregated/combined in dif-
ferent GUVs to produce well-defined conditions for activating 
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biochemical pathways. The effect of confinement on cascade 
reactions has already been characterized in a binary system 
inside smaller polymersomes produced via self-assembly, where 
the enzymatic efficiency was enhanced by the reduced volume 
of the compartment.[25] By using double-emulsion microflu-
idics, high enzymatic concentrations can easily be achieved, 
which consequently increases reaction efficiency, independently 
of the size of the GUV. Moreover, more complex enzymatic 
cascades in synthetic compartments approach the complexity 
of real cells, and the role that compartmentalization plays on 
the outcome of intermediate and final products has previ-
ously not been investigated.[70] In order to demonstrate this, we 
Table 1. Efficiency of encapsulation, EE, and co-encapsulation, cEE, of fluorescence-labeled enzymes (β-gal and GOx) individually loaded in different 
GUVs and loaded together in the same GUV.
β-gal β-gal and GOx GOx GOx and β-gal
(at 655 nm) (at 655 nm) (at 488 nm) (at 488 nm)
Concentration of enzymes in IA, c0 (mg mL−1) 0.235 ± 0.010 – 0.385 ± 0.010 –
Concentration of enzymes in GUVs, ce (mg mL−1) 0.227 ± 0.020 0.109 ± 0.010 0.375 ± 0.030 0.208 ± 0.010
EE/cEE (%) 96.6 ± 9.8 92.8 ± 7.6 97.4 ± 11.0 108.0 ± 9.2
Figure 4. Combinatorial study of a three-step cascade. Representative CLSM images of GUVs containing: a) only β-gal enzymes labeled with Cy5; 
b) only GOx enzymes labeled with Oregon green 488; c) only HRP enzymes labeled with Atto 550. Scale bar: 50  µm. d) Both GOx and β-gal in 
a (43:139) molar proportion. Scale bar: 20  µm. e) All three enzymes, β-gal, GOx, and HRP in a (43:139:1) molar proportion. Scale bar: 10  µm. 
f) Either β-gal or GOx or HRP segregated. Scale bar: 50 µm. g) Scheme of the three-step cascade reaction. Representation of enzymes: ◊ for β-gal; ⬠ 
for GOx; and △ for HRP. Change in fluorescence intensity over time of the products: h–l) fluorescein (485/525 nm); m–q) resorufin (560/600 nm).
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selected a three-enzyme cascade reaction model, which allowed 
the investigation of how reactions can be affected by segregation 
of enzymes inside different spatial organization of GUVs. 
The particular model may be seen as mimicking the pathway 
for the digestion of β galactosides, which plays an important 
role, yet specific for some cells. For instance, in organisms, the 
enzymes can also hydrolyze lactose into galactose and glucose, 
which will further proceed into glycolysis.[71] Thus, the pro-
posed model was based on the following three enzymes: β-gal, 
GOx, and HRP. The first enzyme, β-gal, hydrolyses fluorescein-
di-β-galactopyranoside (FGP) into fluorescein and galactose; in 
the absence of glucose, GOx can oxidize galactose and produce 
hydrogen peroxide (H2O2),[72] which is used by HRP to oxidize 
Amplex Red (AR) into resorufin. This cascade performed by 
well-known enzymes allows accurate identification of which 
phenomena are due to diffusion;[73–75] additionally, the choice 
of FGP instead of the canonical lactose allows two reactions to 
be followed fluorometrically, and to infer the behavior of the 
middle one that does not produce fluorescent species, thus 
providing a deeper insight as to how enzyme activities were 
affected by the three-step cascade in confined spaces. More-
over, we kept the focus on maintaining the relative enzymatic 
concentrations constant for highlighting the versatility of our 
system in providing the many possible physical segregation 
and combinations for studying a multi-step cascade reaction.
Segregating enzymes in independent compartments organ-
ized in different arrangements induces a complex scenario at 
the molecular level because it affects: i) the passage of mole-
cules across semi-permeable membranes (which might be 
reduced due to the pore size), ii creation of non-homogeneous 
concentrations of enzymes, iii) subsequent reactions from the 
cascade that are influenced by the dilution effect, which occurs 
when molecules leave the compartment and enter the bulk 
environment, and iv the probability that molecules enter in 
the ”right” GUV (i.e., that substrates meet the correct enzyme, 
which would allow the sequence of the cascade to operate), 
which decreases with the degree of segregation. These effects 
are thus defined by the cascade topology; in short, where each 
enzymatic reaction takes place relative to each another, and 
to how many membrane passages and dilution steps the sub-
strates and products are subjected.
As a result of constant enzyme molar ratios (β-gal : GOx : HRP, 
43  :  139  :  1), we could study variations of enzyme segregation, 
with enzymes separated from one another and in several com-
binations of encapsulation and co-encapsulation (e.g., three 
enzymes encapsulated together, separated in three different 
GUVs, or only two encapsulated and a third in the bulk). In 
such situations, difference in compartmentalization arrange-
ments is the only dependent variable.
Initially, we studied the cascade in the simplest topology, 
namely encapsulating just one enzyme at the time inside 
GUVs. To conduct the cascade, the complementary enzymes 
were placed in the surroundings, which caused instantaneous 
consumption of the available substrate, and made possible to 
elucidate the effects of molecular passage through OmpF pores 
inserted in the GUV membrane. The production of fluores-
cein (product of the first step of the cascade reaction) depends 
only on the availability of the substrate FGP to β-gal, and the 
reaction is slowed directly when this enzyme is encapsulated 
(Figure  4h). On the contrary, the production of resorufin 
(the final product of the cascade reaction) is affected by the 
whole cascade, especially the availability of substrates, H2O2 
(dependent indirectly on galactose) and Amplex Red to HRP; 
when this enzyme is encapsulated, the overall cascade is like-
wise slowed, once again due to diffusion of HRP substrates 
through the membrane. However, by analyzing the configuration 
where GOx is encapsulated, we obtained the highest produc-
tion of resorufin. As the diffusion of H2O2 to the surroundings 
is fast, we were able to decouple the effects and observed that 
the rate determining step is the slow diffusion of Amplex Red 
into the HRP-loaded GUV, in agreement with the literature.[25] 
In the case of GOx-loaded GUV arrangements, external AP is 
readily available to HRP (Figure 4i).
In arrangements where two enzymes were individually 
encapsulated in different GUVs and the third enzyme was free, 
a somewhat higher degree of segregation was introduced, and 
led to more membrane passages and a lower probability that 
the substrate entered the correct compartment. Mostly, similar 
trends were observed as for single enzyme encapsulation, that 
is, unfavored production of fluorescein and resorufin whenever 
β-gal and HRP were respectively encapsulated (Figure  4j,k). 
Nevertheless, insights into the diffusion of intermediates were 
gained by comparing both arrangements in which HRP was 
encapsulated. In such cases, when, for example, GOx instead 
of β-gal was confined, the diffusion of galactose (produced by 
β-gal) across the membrane of GOx-loaded GUVs slowed 
the process in comparison to GOx free in the surroundings 
(Figure 4k).
Full segregation of enzymes (i.e., the arrangement where 
each enzyme is located in a different compartment) contributed 
significantly to a reduction in production of both fluorescein 
and resorufin, as expected (Figure 4l,m) (Movie S3, Supporting 
Information). This outcome is due to several effects: not only 
must the fluorogenic substrates FGP and Amplex Red cross the 
membrane inward, but also the so called ”bridging molecules,” 
galactose and H2O2, which diffuse out of the GUV where they 
are produced, must enter in the next GUV to reach the enzyme 
for subsequent reaction. Moreover, with such a degree of seg-
regation (three types of compartment), all involved molecules 
have a 66% chance of diffusing into a wrong GUV, which fur-
ther hampers the reaction velocity.
Since we used well-known enzymes, incompatibility issues 
were not expected.[76] However, additional interesting behavior 
of the cascade reaction have been revealed by the possibility 
of positioning enzymes in additional compartmental arrange-
ments based on co-encapsulation of enzymes in one type 
of GUV.
By using a complex setup, in which enzyme couples 
were co-encapsulated, we observed that in the arrangement 
where β-gal and GOx were loaded inside the same GUV (orange 
circle in Figure 4n,o) and HRP inside another one, represented 
by (β-gal+GOx)+(HRP) (Movie S4, Supporting Information), the 
amount of resorufin produced was curiously lower than in the 
alternative arrangement, in which β-gal was alone in one GUV 
and GOx and HRP were encapsulated together in a second, 
(β-gal)+(GOx+HRP) (cyan circle in Figure  4n,o). This seems 
to contradict fast diffusion of H2O2, but what actually happens 
is that GOx is competitively inhibited by the excess of H2O2,[77] 
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which due to the distance introduced by the compartmentaliza-
tion, cannot be as rapidly consumed and a harmful environment 
develops. Moreover, we also consider the possibility that H2O2 
may have originated from a second oxidation of the highly con-
centrated metabolite d-galacto-1,5-lactone, thus aggravating the 
suppression of GOx activity, as the d-galacto-1,5-lactone derived 
from d-glucose is also a substrate for GOx.[78] Nevertheless, 
due to the proximity of enzymes offered by co-encapsulation 
in the arrangement (β-gal)+(GOx+HRP), HRP accesses H2O2 
immediately and converts it into resorufin. An interesting situ-
ation happened in the arrangement where β-gal and HRP were 
located inside the same GUV (purple circle in Figure 4n,o) and 
GOx inside another one, represented by (β-gal+HRP)+(GOx). 
In this arrangement, both bridging molecules (galactose and 
H2O2) should travel between GUVs, a topologically similar situ-
ation to all enzymes segregated), which, as already discussed, 
would decrease the resorufin production rate. However, the 
result is quite the opposite, and much larger production of 
resorufin was coupled to almost no fluorescein signal. This 
behavior rises because HRP, besides oxidizing H2O2, can also 
oxidize the fluorescein released by hydrolysis of FGP into non-
fluorescent compounds;[79] this reaction is favored because 
H2O2 is produced in the other GOx-loaded GUV, which ham-
pers its access to HRP. Furthermore, decomposition of fluores-
cein produces the radical hydroxyl (·OH), which is a potent and 
non-specific oxidizing agent. Amplex Red was thus oxidized 
both by the combination HRP + H2O2 and by ·OH, leading 
to a drastic increase in resorufin production.[80] This side reac-
tion would have not been observed in bulk samples at the same 
concentration, but segregation hindered diffusion, and allowed 
us to observe it (Figure 4n,o). The presence of fluorescein and 
HRP in the same GUV resulted in an unwanted, secondary 
reaction, which quenched one desired product, but at the same 
time improved the overall cascade efficiency, since enhancing 
the production of resorufin was the ultimate objective.
Finally, on the basis of a thorough investigation of the condi-
tions to be avoided and to be exploited, the best arrangement 
naturally falls into complete co-encapsulation. By profiting 
from control over the inner GUV compositions that our 
microfluidic technique can offer, all three enzymes were easily 
co-encapsulated, while maintaining constant stoichiometry. 
Fluorescein production could be tuned by virtue of the proximity 
of enzymes and metabolites, which favored consumption of 
Amplex Red over fluorescein (Figure 4p). Moreover, the overall 
activity (i.e., the production of resorufin, in the last step) was 
remarkably improved, assisted partially by the oxidation of 
fluorescein to yield ·OH that in turn produced more resorufin 
(Figure  4q) (Movie S5, Supporting Information). With this 
arrangement, optimal conditions for maximum rates of produc-
tion were accomplished.
We have developed a general strategy to study and optimize 
multi-step enzymatic reactions in synthetic confined spaces, 
based on biomimicry, and taking advantage of the high preci-
sion double emulsion technique. In this regard, an improved 
six-way junction geometry fabricated in silicon-glass devices, 
together with optimized fluid flow rates, provided a precise and 
high-throughput break-up of droplets in a single step, which 
guaranteed highly efficient biomolecular encapsulation and 
yielded 100% production of monodispersed double emulsions 
surrounded by a thin organic shell. These characteristics ena-
bled the formation of GUVs, which constituted ideal supramo-
lecular structures for insertion of biochannels. Accordingly, we 
demonstrated that the biopore, gramicidin, and the membrane 
protein, OmpF, preserved functionality when inserted in GUVs 
formed with the PDMS26-b-PMOXA9 block copolymer, whose 
membrane presented the required fluidity and flexibility to 
overcome the significant hydrophobic mismatch between its 
thickness and the formed pore. Moreover, the double emul-
sion technique allowed for an unprecedented control over the 
absolute and relative amounts of enzymes inside compart-
ments, which besides enabling simultaneous co-encapsulation 
of three enzymes inside the cavity of single polymer GUV, 
allowed the presentation of high enzyme concentrations, in 
molecular proximity for optimizing the biochemical pathways. 
Overall, tailored cell-sized polymer GUVs, equipped with pep-
tides/membrane proteins, and containing one or more types of 
encapsulated enzyme, were produced in a controlled manner 
as synthetic compartments that mimic elements of a complex 
cellular environment.
By mastering positional control of enzymes, we conducted 
a three-step cascade reaction in a variety of cascade topolo-
gies. A straightforward combinatorial study allowed special 
reaction effects to be identified which were not expected from 
model cascades based on well-known enzymes. Not only were 
we able to determine configurations to avoid, because of com-
peting reactions, but more importantly we were able to estab-
lish the optimum reaction conditions, and to benefit from 
initially unwanted effects by enhancing the overall cascade effi-
ciency and maximizing production of the final reaction product 
(resorufin). These important findings could not have been 
realized in a bulk reaction, nor in a single synthetic compart-
ment of the same type, and highlights the necessity for working 
with multiple compartmentalization. In this respect, the cur-
rent work provides a foundation for studying and optimizing 
cascade reactions only by physical means, much as cells do via 
subcellular segregation, without the time consuming and dif-
ficult work of varying relative enzymatic concentrations.
Our novel methodology described here can be applied to 
any multi-step cascade reactions, and offers the possibility of 
discovering unwanted pathways, determining the production 
of undesirable intermediates, and identifying other routes in 
which toxic products are rapidly consumed. These stages can 
all benefit from effective, controlled, and high-throughput pro-
cesses, which ultimately can contribute to faster and cheaper 
results for improving the science and making new discoveries.
Experimental Section
Chemicals: Phosphate-buffered saline solution (Dulbecco's 1X PBS, 
without Ca2 +/Mg2 +) was purchased from BioConcept. Poly(vinyl alcohol) 
(PVA, Mw  = 13–23 kDa), poly(ethylene glycol) (PEG, Mw  = 6 kDa), 
poly(ethyleneimine) solution 50 wt% in H2O, chloroform 99%, hexane 
anhydrous 95%, RGP, FGP, gramicidin from Bacillus aneurinolyctus 
(Bacillus brevis, gA), sucrose, carboxyfluorescein (CF), fluorescein 
isothiocyanate–dextran (FITC-dextran), potassium phosphate dibasic 
(K2HPO4), potassium phosphate monobasic (KH2PO4), and sodium 
chloride (NaCl) were obtained from Sigma-Aldrich and were used as 
received. Amplex Ultra Red (AR) was obtained from Invitrogen. Aquapel 
was obtained from PPG Industries. BODIPY 630/650 and the NHS 
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esters, Cy5, Oregon Green, and ATTO 550 were purchased from Thermo 
Fisher Scientific. Sodium Green (SG) was purchased from TEFLabs Inc.
Synthesis and Characterization of PDMS26-b-PMOXA9: The synthesis of 
the amphiphilic diblock copolymer poly(dimethyl siloxane)-block-poly(2-
methyl-2-oxazoline) (PDMS26-b-PMOXA9) was conducted according to 
amended, previously reported protocols (Supporting Information).[47,48] 
Briefly, PDMS was synthesized by anionic ring opening polymerization 
of hexamethylcyclotrisiloxane (D3), and the hydride-terminated PDMS-H 
was then transformed into monocarbinol-functionalized PDMS-OH 
with 2-allyloxyethanol. Activation for the following chain extension was 
done with trifluormethanesulfonic anhydride. Subsequently, 2-methyl-
2-oxazoline (MOXA) was polymerized in a cationic ring-opening 
polymerization, followed by quenching with triethylamine and water. The 
average composition of the hydroxy-terminated copolymer was found 
to be PDMS26-b-PMOXA9, and corresponded to a molecular weight of 
Mn  = 2800 g mol−1 determined by 1H-NMR spectroscopy (Figure  S3, 
Supporting Information). The molecular weight distribution was 
measured by gel permeation chromatography and showed a dispersity 
of Ð = 1.21 (Figure S4, Supporting Information).
OmpF Expression: The wild-type outer membrane protein F (OmpF) 
was obtained according to the same procedure already reported.[25]
Composition of Fluid Phases: The different compositions of IA, PO, and 
OA phases used in the experiments were as follows. Inner aqueous phase 
(IA): If not otherwise stated, all solutions were prepared with the starting 
composition of 20 w/v% of PEG and 300 × 10−3 m of sucrose in PBS solution 
(≈628 mOsm L−1); 10  × 10−6 m carboxyfluorescein (CF) (Figure  2e–h); 
198 × 10−6 m β-gal (l.h.s of Figure 3b); 0.25 mg mL−1 β-gal, 0.25 mg mL−1 
GOx, and 0.5  µg mL−1 HRP (Figure  4a–c,f,h–q); 0.125 mg mL−1 β-gal, 
0.125 mg mL−1 GOx (Figure  4d); 0.083 mg mL−1 β-gal, 0.083 mg mL−1 
GOx, and 0.167  µg mL−1 HRP; 10 × 10−6 m Sodium Green (SG), 3 × 10−6 m 
gramicidin (gA) in buffer K (experiments aimed at detecting the signaling 
of the ion Na+, Figure 3a); ”buffer K” contained: 300 × 10−3 m of K2HPO4, 
300 × 10−3 m of KH2PO4 added to 20 w/v% of PEG, and 300 × 10−3 m of 
sucrose in Milli-Q water (Milipore, resistivity of 18.2 MΩ cm−1), at pH = 7.4. 
Polymer organic phase (PO): 6 mg mL−1 of PDMS26-b-PMOXA9 in 3:2 v/v 
hexane:chloroform solution. Outer aqueous phase (OA): if not otherwise 
stated, solutions were prepared with 5 w/v% of PVA in PBS solution 
(≈298 mOsm L−1); 0.39 × 10−3 m OmpF (r.h.s. of Figures 3b,c and 4h–q). 
Collection phase (CP): If not otherwise stated, solutions were prepared 
with 700 × 10−3 m NaCl, 5 w/v% PVA in PBS solution (≈1628 mOsm L−1); 
700 × 10−3 m KCl, 5 w/v% PVA in buffer K solution (Figure 3a).
Operation of The Microfluidic Device: Immiscible fluids were infused 
into the microdevice (Figure 1) using a three module precision syringe 
pump (low pressure neMESYS, Cetoni). The fluid phases were fed 
at different flow rates, in particular, when conducting optimization 
of the double emulsion sizes (Figure  2). For all other experiments, 
the phases IA, PO, and OA were set to flow rates of 2, 1, and 
50  µL min−1, respectively. Double emulsion drops were prepared by 
one-step emulsification and collected for 10 min in a vial containing 
200 µL of the CP solution, where they rapidly sank due to the difference 
in density caused by the addition of sucrose in the IA phase. Note that 
the difference in osmolarity created between IA phase and the solution 
surrounding the collected droplets was roughly 70 mOsm L−1. Upon 
separation of the oil phase and dewetting up to equilibrium, polymer 
GUVs were produced.
Imaging: Double Emulsion Size Measurements: The microfluidic 
production of double-emulsion drops using a High Speed Digital 
Microscope (Meros, Dolomite) was recorded. A 5× objective equipped 
with a high-speed camera (1.3 megapixel colour camera, 1/2” CMOS 
sensor) was used to capture videos of double emulsions flowing in 
the main channel of the microchip, and these were further processed 
with the custom Matlab code to measure the droplet’s inner core and 
outer shell diameters (the exact procedure is described in Supporting 
Information).
Imaging: GUV Functionalities and Size Measurements: GUVs were 
visualized in Nunc Lab-Tek eight-well chambers (Thermo Fisher 
Scientific, USA) using a Zeiss 880 CLSM microscope (Zeiss, Germany) 
with an objective (C-Apochromat 10× and 20×/1.2 W Korr FCS M27). 
To the suspension of GUVs (20 µL), together with a final concentration 
of 5 × 10−6 m of BODIPY 630/650 (5 µL), the following solutions were 
added to a total volume of 200 µL of collection phase (CP) in separated 
experiments, namely: i) 5 × 10−6 m RGP (Figure 3b), ii) 200 × 10−6 m of 
FITC-dextran (l.h.s of Figure 3c), iii) 200 × 10−6 m of CF (r.h.s of Figure 3c) 
and iv) 3.75 × 10−6 m FGP and 2.5 × 10−6 m Amplex Red (Movies S3–S5, 
Supporting Information). GUVs were imaged by BODIPY 630/650 
staining the membrane to discriminate between hollow vesicles and 
eventual non separated organic phase droplets. For imaging GUVs, a 
488 nm argon laser, a 561 nm DPSS 5561-10 laser, and a 633 nm HeNe 
laser were used. For CF, OregonGreen, and FITC-dextran, an argon laser 
(488 nm) was used, with 493–629 nm filters, MBS 488; for resorufin and 
ATTO 550, a DPSS (561 nm) laser was used, with 563–629 nm filters, 
MBS T80/R20; and for BODIPY and Cy5, a diode laser (633 nm) was 
used, MBS 488/561/ 633. The pinhole aperture was always 39 µm.
Images of GUVs acquired with the bright field were used for 
measuring GUV diameters via an image processing software written in 
Matlab (the exact procedure is described in Supporting Information).
Enzyme Labeling: Solutions of 2 mg mL−1 of β-gal, GOx, and HRP 
were prepared in PBS (pH adjusted to 8) and 3 molar equivalents of 
NHS ester reactive dyes: Cy5 (for β-gal), OregonGreen (for GOx), and 
Atto 550 (for HRP) were added. After an overnight reaction at room 
temperature, enzyme solutions were purified by centrifugation (Minispin 
Plus, Eppendorf) using filters (Amicon ultra 30 K, Merck) for 15 cycles 
of 5 min at maximum speed, using PBS as eluent. Subsequently, the 
resulting purified concentrate of labeled enzymes were diluted in the 
inner aqueous phase, containing 20 w/v% of PEG and 300 × 10−3 m 
of sucrose in PBS solution (75  µL in 500  µL) to obtain the solutions 
used for the formation of GUVs. The number of molecules of dye per 
number of molecules of enzymes was determined using fluorescent 
correlation spectroscopy (FCS). This method measures the fluctuations 
of the fluorescence intensity of fluorophores due to Brownian motion 
in femtoliter-sized confocal volumes. By dividing the counts per 
molecule (CPM, kHz) of labeled enzymes by the CPM of free dyes, an 
average number of 1.22 molecules of Cy5 per molecule of β-gal and 1.02 
molecules of OregonGreen per molecule of GOx and 1.21 molecules of 
Atto 550 per molecule of HRP were obtained (Figure  S8, Supporting 
Information). The remaining quantity of free dyes present in solution was 
also determined by FCS using a 2-component fit: only 0.27% of free Cy5, 
1.7% of free Oregon green, and 0.53% of Atto 550 remained in solution.
Determination of the Confocal Volumes: To determine the amount of 
fluorescent-labeled enzymes encapsulated inside GUVs, the confocal 
volumes corresponding to both laser lines (488 and 633 channels) used 
to measure the fluorescent-labeled enzymes were calculated. To do so, 
solutions of fluorescent dyes with known diffusion coefficients—Atto 488 
(D = 4 × 1010 m2 s−1) and Atto 655 (D = 4.26 × 1010 m2 s−1)—were measured. 
Assuming that the confocal volume can be approximated by a 3D Gaussian 
shape, the temporal autocorrelation function can be measured, as follows:
G t G t t
k




τ τ( ) ( )= + +
− −
 (1)
Equation (1) results from the correlation of a time series, where G0 is 
the correlation amplitude, k is the eccentricity of the confocal volume, 
and τ is the lag-time for which the correlation has dropped to half of 
its maximum. Thus, from the correlated data (corresponding to each 
dye) fitted with Equation (1), the structural parameters, k = 5, τ = 35 µs 
for Atto 488, and τ  = 54  µs for Atto 655, were obtained (Figure  S8, 
Supporting Information). The effective volumes Veff for each dye 
(Veff = 0.373 fL for the 488 line and Veff = 0.784 fL for the 633 line) were 
calculated using
V k D4eff
3/2πτ( )=  (2)
Finally, the confocal volumes (Vconf  = 0.132 fL for 488 line and 
Vconf = 0.227 fL for 633 line) were calculated using
V V 1
2conf eff
3/2( )=  (3)
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The lasers were used with 5% attenuation for the 488 line 
(ArgonRemote) and 10% attenuation for the 633 line (HeNe633), for the 
FCS measurements and the determination of confocal volumes.
Determination of the Concentration of Enzymes Inside GUVs: To 
determine the concentration of the enzymes in the solutions, the 
average number of particles present in the confocal volumes was also 
determined by FCS. Then knowing the number of enzymes present in 
the confocal volumes and the volume of the confocal volumes, the 
concentration of enzyme solutions was calculated and concentrations 
of 0.23 ± 0.01 mg mL−1 and 0.38 ± 0.01 mg mL−1 for the final solutions of 
β-gal and GOx, respectively, obtained. To determine the concentration 
of enzymes inside GUVs, brightness was measured via FCS in GUVs 
(N  = 3) encapsulating one or two enzymes using a 2-component fit 
with a fixed diffusion time for each enzymes (Figure  S9, Supporting 
Information). Knowing the volume of GUVs (approximately 3 × 104 fL), 
and using the same method as for the free enzyme solutions, the 
average number of enzymes in the confocal volumes were determined. 
The concentrations of enzymes per GUV were: 0.23 ± 0.02 mg mL−1 
for β-gal and 0.38 ± 0.03 mg mL−1 461 for GOx when encapsulated 
separately, and 0.11 ± 0.01 mg mL−1 for β-gal and 0.21 ± 0.01 mg mL−1 
when co-encapsulated. The dilution factor (approximately 2) obtained 
for the co-encapsulation compared to separate encapsulation was 
consistent with the dilution of enzymes, and to account for it, 
concentrations of enzymes that were co-encapsulated in GUVs were 
multiplied by 2.
Monitoring Enzymatic Reactions: Enzymatic assays were performed 
using a Spectramax iD3 microplate reader (Molecular Devices, USA) 
in a 96-well, flat-bottomed black plate (Corning, USA) for fluorescence. 
Both β-gal and GOx were added to a final concentration of 12.5 µg mL−1 
and HRP to a final concentration of 50 ng mL−1, either encapsulated or 
free in solution, 3.75  × 10−6 m FGP, and 2.5  × 10−6 m Amplex Red and 
the volume was brought to 200 µL with the collection phase (PVA/PBS/
NaCl). The production of fluorescein (from FGP) was followed at Ex: 485 
nm Em: 525 nm, for resorufin (from Amplex Red) at Ex: 560 Em: 600 
nm, every 30 s, for 20 min.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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